Manpower Software PLC
02 December 2003
MANPOWER SOFTWARE PLC ("the Company")
AWARD OF CONTRACT
Manpower Software plc is pleased to announce a new contract for the sale of its
MAPS FORGE Force Generation software to the UK Defence Medical Services ("DMS").
The value of the contract is approximately £1.2 million over 4 1/2 years.
DMS, the tri-service organisaton responsible for providing medical capability to
the UK Armed Forces, will use MAPS to plan and manage deployment and training of
their medical staff throughout the Reserve Forces and the Regular Forces within
the Defence Medical Education and Training Agency and the Defence Dental Agency.
The DMS medical staff consists of approximately 7,000 doctors, dentists, nurses,
technicians and allied health professionals.
This order follows the agreements announced in May and September 2003 for the
sale of MAPS to HQ Land Command, British Army for use as the force generation
tool of the Territorial Army and the Regular Army. DMS will represent the first
tri-service installation of MAPS.
Enquiries:
Manpower Software plc
Simon Thorne, Finance Director 020 7389 9500
Strand Partners Limited
Rory Murphy, Director 020 7409 3494
Shore Capital
Alex Borrelli, Director 020 7408 4090
Dated 2 December 2003
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.